Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 9, 2012, Pages 925-929

  Schuller, Joseph L ^a   Zipse, Matthew ^a   Crawford, Thomas ^a   Bogun, Frank ^a   Beshai, John ^a   Patel, Amit R ^a   Sweiss, Nadera J ^a   Nguyen, Duy T ^a   Aleong, Ryan G ^a   Varosy, Paul D ^a   Weinberger, Howard D ^a   Sauer, William H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiac sarcoid; Cardiomyopathy; Heart failure; Implantable cardioverter defibrillator; Ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOIDOSIS; SECONDARY PREVENTION; SUDDEN DEATH;

ADULT; AGED; COHORT STUDIES; DEATH, SUDDEN; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS;

EID: 84870432653     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02350.x     Document Type: Article

References (11)

1. Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL, deGennesC, Papo T,BlétryO,Godeau P, Piette JC:Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore) 2004;83:315-334.
2. Silverman KJ, Hutchins GM, Bulkley BH: Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-1211.
3. Perry A, Vuitch F: Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-172.
4. RobertsWC, McAllister HA Jr, Ferrans VJ: Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108.
5. Ferrans VJ, HibbsS RG, Black WC, Walsh JJ, Burch GE: Myocardial degeneration in cardiac sarcoidosis: Histochemical and electron microscopic studies. Am Heart J 1965;69:159-172.
6. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, HlatkyMA, Newby LK, Page RL, Schoenfeld MH, SilkaMJ, Stevenson LW, Sweeney MO:ACC/AHA/HRS 2008 Guidelines forDevice-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-e408.
7. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK: Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52(7):541-550.
8. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
9. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME: Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-2665.
10. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D: Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004;109:1503-1508.
11. Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI: Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010;122:1144-1152.